Palestinian private sector employees strike demanding abolition of Social Security Law
January 16, 2019
RAMALLAH, Tuesday, January 15, 2019 (WAFA) – Employees of the Palestinian private sector in the West Bank observed a general strike on Tuesday as thousands staged a sit-in protest outside the Social Security Corporation headquarters in al-Bireh calling for scrapping the controversial Social Security Law.
Shops, businesses, factories, financial institutions and private schools were shuttered in main cities across the West Bank heeding calls"...
Japan, Israeli cooperate in medical field
January 13, 2019
Tokyo, Jan.12 (Petra) -- The Japanese and Israeli governments will embark this month on a cooperative effort to synergize their strengths in medical care fields, media sources said.
Economy, Trade and Industry Minister Hiroshige Seko is scheduled to visit Israel in mid-January to sign a memorandum for the planned cooperation, the sources said.
Seko is expected to confirm the cooperation on a government level, and representatives from about 100 Japanese companies will accompany the minister to sign"...
Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna
January 4, 2019
Boehringer Ingelheim and Dicerna Pharmaceuticals (NASDAQ: DRNA), a leading developer of investigational RNA interference (RNAi) therapeutics, today announced that Boehringer Ingelheim has exercised an option to receive exclusive rights to a second hepatic disease target emerging from its research collaboration and license agreement with Dicerna. The collaboration, established in October 2017, aims to discover and develop novel GalXC™ RNAi therapeutics for the treatment of chronic liver diseases, with an initial focus on nonalcoholic steatohepatitis (NASH), a devastating disease for which there is no approved treatment. The option is the second target under the two companies’ research collaboration and license agreement. Under the terms of the agreement, Boehringer Ingelheim will be responsible for future clinical development and commercialization of the therapeutic target. Dicerna is eligible to receive development and commercial milestone payments, and royalties on worldwide net sales. “It is extremely gratifying for Boehringer Ingelheim to exercise......
$350 million appeal to address critical humanitarian needs of Palestinians launched
December 18, 2018
RAMALLAH, Monday, December 17, 2018 (WAFA) - The Minister of Social Development Ibrahim al-Shaer and the United Nations Humanitarian Coordinator Jamie McGoldrick launched on Monday the Humanitarian Response Plan (HRP) for 2019 in the occupied Palestinian territory (oPt), according to a joint press release by the Ministry of Social Development and the United Nations Office for the Coordination of Humanitarian Affairs (OCHA) in the occupied Palestinian territory.
The"...